Everolimus

FDA Approved: * June 8, 2020
Pharm Company: * WEST-WARD PHARMS INT
Category: Cancer

Everolimus, sold under the brand name Afinitor among others, is a medication used as an immunosuppressant to prevent rejection of organ transplants[8] and as a targeted therapy in the treatment of renal cell cancer and other tumours.[9] It is the 40-O-(2-hydroxyethyl) derivative of sirolimus and works similarly to sirolimus as an inhibitor of mammalian target of rapamycin (mTOR).[10] It is marketed by Novartis under the trade names Zortress (US)... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
3 Discussions

Dosage List

Everolimus .25 mg Oral Tablet
NDC: 0054-0470
Labeler:
Hikma Pharmaceuticals USA Inc.
Everolimus .5 mg Oral Tablet
NDC: 0054-0471
Labeler:
Hikma Pharmaceuticals USA Inc.
Everolimus .75 mg Oral Tablet
NDC: 0054-0472
Labeler:
Hikma Pharmaceuticals USA Inc.
Everolimus 2.5 mg Oral Tablet
NDC: 0054-0480
Labeler:
Hikma Pharmaceuticals USA Inc.
Everolimus 5 mg Oral Tablet
NDC: 0054-0481
Labeler:
Hikma Pharmaceuticals USA Inc.
Everolimus 10 mg Oral Tablet
NDC: 0054-0482
Labeler:
Hikma Pharmaceuticals USA Inc.
Everolimus 7.5 mg Oral Tablet
NDC: 0054-0497
Labeler:
Hikma Pharmaceuticals USA Inc.
Everolimus 1 mg Oral Tablet
NDC: 0054-0604
Labeler:
Hikma Pharmaceuticals USA Inc.
Everolimus 2.5 mg Oral Tablet
NDC: 0093-7766
Labeler:
Teva Pharmaceuticals USA, Inc.
Everolimus 5 mg Oral Tablet
NDC: 0093-7767
Labeler:
Teva Pharmaceuticals USA, Inc.

Related Brands

Drugs with the same active ingredients

Popular Topics

Everolimus Face Rash

Side Effects of Everolimus including face and body rash; swollen feet...

Everolimus Side Effects

Everolimus Side Effects: Face and Body Rash...